• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 - Product Image

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

  • Published: August 2012
  • Region: Africa, Brazil, China, India, Russia, South Africa
  • 207 Pages
  • GlobalData

FEATURED COMPANIES

  • Baxter International Inc.
  • Biomet, Inc.
  • DePuy, Inc.
  • DJO Finance LLC
  • Ferring International C
  • Genzyme Corporation
  • MORE

Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Summary

Our new report, “Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018” provides key market data on the Orthobiologics market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within four market categories – Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators. The report also provides company shares and distribution shares data for the overall Orthobiologics market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Market size data for Orthobiologics market categories - Bone Graft Substitutes, Bone Allografts, Viscosupplementation and Bone Growth Stimulators.

- READ MORE >

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Orthobiologics in BRICS
3.1 Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
3.2 Orthobiologics, BRICS, Company share (2010-2011)
4 Orthobiologics In Brazil
4.1 Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
4.2 Bone Graft Substitutes In Brazil
4.2.1 Bone Graft Substitutes, Brazil, Overall Revenue (2004-2018)
4.2.2 Bone Graft Substitutes, Brazil, Overall Volume (2004-2018)
4.2.3 Bone Graft Substitutes, Brazil, Average Price (2004-2018)
4.3 Bone Allografts In Brazil
4.3.1 Bone Allografts, Brazil, Overall Revenue (2004-2018)
4.4 Viscosupplementation In Brazil
4.4.1 Viscosupplementation, Brazil, Overall Revenue (2004-2018)
4.4.2 Viscosupplementation, Brazil, Overall Volume (2004-2018)
4.4.3 Viscosupplementation, Brazil, Average Price (2004-2018)
4.5 Bone Growth Stimulators In Brazil
4.5.1 Bone Growth Stimulators, Brazil, Overall Revenue (2004-2018)
4.5.2 Bone Growth Stimulators, Brazil, Overall Volume (2004-2018)
4.5.3 Bone Growth Stimulators, Brazil, Average Price (2004-2018)
4.6 Orthobiologics, Brazil, Distribution Share (2010-2011)
4.7 Orthobiologics, Brazil, Company Share (2010-2011)
5 Orthobiologics In Russian Federation
5.1 Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
5.2 Bone Graft Substitutes In Russian Federation
5.2.1 Bone Graft Substitutes, Russian Federation, Overall Revenue (2004-2018)
5.2.2 Bone Graft Substitutes, Russian Federation, Overall Volume (2004-2018)
5.2.3 Bone Graft Substitutes, Russian Federation, Average Price (2004-2018)
5.3 Bone Allografts In Russian Federation
5.3.1 Bone Allografts, Russian Federation, Overall Revenue (2004-2018)
5.4 Bone Growth Stimulators In Russian Federation
5.4.1 Bone Growth Stimulators, Russian Federation, Overall Revenue (2004-2018)
5.4.2 Bone Growth Stimulators, Russian Federation, Overall Volume (2004-2018)
5.4.3 Bone Growth Stimulators, Russian Federation, Average Price (2004-2018)
5.5 Viscosupplementation In Russian Federation
5.5.1 Viscosupplementation, Russian Federation, Overall Revenue (2004-2018)
5.5.2 Viscosupplementation, Russian Federation, Overall Volume (2004-2018)
5.5.3 Viscosupplementation, Russian Federation, Average Price (2004-2018)
5.6 Orthobiologics, Russian Federation, Distribution Share (2010-2011)
5.7 Orthobiologics, Russian Federation, Company Share (2010-2011)
6 Orthobiologics In India
6.1 Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018
6.2 Bone Graft Substitutes In India
6.2.1 Bone Graft Substitutes, India, Overall Revenue (2004-2018)
6.2.2 Bone Graft Substitutes, India, Overall Volume (2004-2018)
6.2.3 Bone Graft Substitutes, India, Average Price (2004-2018)
6.3 Bone Allografts In India
6.3.1 Bone Allografts, India, Overall Revenue (2004-2018)
6.4 Viscosupplementation In India
6.4.1 Viscosupplementation, India, Overall Revenue (2004-2018)
6.4.2 Viscosupplementation, India, Overall Volume (2004-2018)
6.4.3 Viscosupplementation, India, Average Price (2004-2018)
6.5 Bone Growth Stimulators In India
6.5.1 Bone Growth Stimulators, India, Overall Revenue (2004-2018)
6.5.2 Bone Growth Stimulators, India, Overall Volume (2004-2018)
6.5.3 Bone Growth Stimulators, India, Average Price (2004-2018)
6.6 Orthobiologics, India, Distribution Share (2010-2011)
6.7 Orthobiologics, India, Company Share (2010-2011)
7 Orthobiologics In China
7.1 Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018
7.2 Bone Graft Substitutes In China
7.2.1 Bone Graft Substitutes, China, Overall Revenue (2004-2018)
7.2.2 Bone Graft Substitutes, China, Overall Volume (2004-2018)
7.2.3 Bone Graft Substitutes, China, Average Price (2004-2018)
7.3 Bone Allografts In China
7.3.1 Bone Allografts, China, Overall Revenue (2004-2018)
7.4 Viscosupplementation In China
7.4.1 Viscosupplementation, China, Overall Revenue (2004-2018)
7.4.2 Viscosupplementation, China, Overall Volume (2004-2018)
7.4.3 Viscosupplementation, China, Average Price (2004-2018)
7.5 Bone Growth Stimulators In China
7.5.1 Bone Growth Stimulators, China, Overall Revenue (2004-2018)
7.5.2 Bone Growth Stimulators, China, Overall Volume (2004-2018)
7.5.3 Bone Growth Stimulators, China, Average Price (2004-2018)
7.6 Orthobiologics, China, Distribution Share (2010-2011)
7.7 Orthobiologics, China, Company Share (2010-2011)
8 Orthobiologics In South Africa
8.1 Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
8.2 Bone Graft Substitutes In South Africa
8.2.1 Bone Graft Substitutes, South Africa, Overall Revenue (2004-2018)
8.2.2 Bone Graft Substitutes, South Africa, Overall Volume (2004-2018)
8.2.3 Bone Graft Substitutes, South Africa, Average Price (2004-2018)
8.3 Bone Allografts In South Africa
8.3.1 Bone Allografts, South Africa, Overall Revenue (2004-2018)
8.4 Viscosupplementation In South Africa
8.4.1 Viscosupplementation, South Africa, Overall Revenue (2004-2018)
8.4.2 Viscosupplementation, South Africa, Overall Volume (2004-2018)
8.4.3 Viscosupplementation, South Africa, Average Price (2004-2018)
8.5 Bone Growth Stimulators In South Africa
8.5.1 Bone Growth Stimulators, South Africa, Overall Revenue (2004-2018)
8.5.2 Bone Growth Stimulators, South Africa, Overall Volume (2004-2018)
8.5.3 Bone Growth Stimulators, South Africa, Average Price (2004-2018)
8.6 Orthobiologics, South Africa, Distribution Share (2010-2011)
8.7 Orthobiologics, South Africa, Company Share (2010-2011)
9 Overview of Key Companies in BRICS Orthobiologics Market
9.1 DePuy, Inc.
9.1.1 Company Overview
9.1.2 Share in the BRICS Orthobiologics Market
9.2 Genzyme Corporation
9.2.1 Company Overview
9.2.2 Share in the BRICS Orthobiologics Market
9.3 Synthes, Inc.
9.3.1 Company Overview
9.3.2 Share in the BRICS Orthobiologics Market
9.4 Medtronic, Inc.
9.4.1 Company Overview
9.4.2 Share in the BRICS Orthobiologics Market
9.5 Baxter International Inc.
9.5.1 Company Overview
9.5.2 Share in the BRICS Orthobiologics Market
9.6 Biomet, Inc.
9.6.1 Company Overview
9.6.2 Share in the BRICS Orthobiologics Market
9.7 Orthofix International N.V.
9.7.1 Company Overview
9.7.2 Share in the BRICS Orthobiologics Market
9.8 Smith & Nephew Plc
9.8.1 Company Overview
9.8.2 Share in the BRICS Orthobiologics Market
9.9 Globus Medical, Inc.
9.9.1 Company Overview
9.10 Wright Medical Group, Inc.
9.10.1 Company Overview
9.10.2 Share in the BRICS Orthobiologics Market
9.11 Stryker Corporation
9.11.1 Company Overview
9.11.2 Share in the BRICS Orthobiologics Market
9.12 DJO Finance LLC
9.12.1 Company Overview
9.12.2 Share in the BRICS Orthobiologics Market
9.13 Ferring International Center S.A.
9.13.1 Company Overview
9.13.2 Share in the BRICS Orthobiologics Market
9.14 Seikagaku Corporation
9.14.1 Company Overview
9.15 Anika Therapeutics, Inc.
9.15.1 Company Overview
9.15.2 Share in the BRICS Orthobiologics Market
9.16 Alphatec Holdings, Inc.
9.16.1 Company Overview
9.16.2 Share in the BRICS Orthobiologics Market
9.17 NuVasive, Inc.
9.17.1 Company Overview
10 Appendix
10.1 Definitions of Markets Covered in the Report
10.1.1 Orthobiologics
10.2 Research Methodology
10.3 Secondary Research
10.4 Primary Research
10.5 Models
10.6 Forecasts
10.7 Expert Panels
10.8 Consulting
10.9 Currency Conversion
10.10 Contact Us
10.11 Disclaimer

1.1 List of Tables
Table 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 4: Orthobiologics, BRICS, Company share by Revenue ($m), USD Constant, 2010-2011
Table 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Table 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Table 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Table 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011
Table 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018
Table 12: Bone Graft Substitutes, Brazil, Average Price ($), Historic, 2004-2011
Table 13: Bone Graft Substitutes, Brazil, Average Price ($), Forecast, 2011-2018
Table 14: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 15: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 16: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 17: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 18: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011
Table 19: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018
Table 20: Viscosupplementation, Brazil, Average Price ($), Historic, 2004-2011
Table 21: Viscosupplementation, Brazil, Average Price ($), Forecast, 2011-2018
Table 22: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Table 23: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 24: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011
Table 25: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018
Table 26: Bone Growth Stimulators, Brazil, Average Price ($), Historic, 2004-2011
Table 27: Bone Growth Stimulators, Brazil, Average Price ($), Forecast, 2011-2018
Table 28: Orthobiologics, Brazil, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 29: Orthobiologics, Brazil, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 30: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Table 31: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 32: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 33: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Table 34: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Table 35: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011
Table 36: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018
Table 37: Bone Graft Substitutes, Russian Federation, Average Price ($), Historic, 2004-2011
Table 38: Bone Graft Substitutes, Russian Federation, Average Price ($), Forecast, 2011-2018
Table 39: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 40: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 41: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 42: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 43: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011
Table 44: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018
Table 45: Bone Growth Stimulators, Russian Federation, Average Price ($), Historic, 2004-2011
Table 46: Bone Growth Stimulators, Russian Federation, Average Price ($), Forecast, 2011-2018
Table 47: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Table 48: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 49: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011
Table 50: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018
Table 51: Viscosupplementation, Russian Federation, Average Price ($), Historic, 2004-2011
Table 52: Viscosupplementation, Russian Federation, Average Price ($), Forecast, 2011-2018
Table 53: Orthobiologics, Russian Federation, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 54: Orthobiologics, Russian Federation, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 55: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018
Table 56: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 57: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 58: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Table 59: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Table 60: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011
Table 61: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018
Table 62: Bone Graft Substitutes, India, Average Price ($), Historic, 2004-2011
Table 63: Bone Graft Substitutes, India, Average Price ($), Forecast, 2011-2018
Table 64: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 65: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 66: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 67: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 68: Viscosupplementation, India, Volume (Units), Historic, 2004-2011
Table 69: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018
Table 70: Viscosupplementation, India, Average Price ($), Historic, 2004-2011
Table 71: Viscosupplementation, India, Average Price ($), Forecast, 2011-2018
Table 72: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011
Table 73: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 74: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011
Table 75: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018
Table 76: Bone Growth Stimulators, India, Average Price ($), Historic, 2004-2011
Table 77: Bone Growth Stimulators, India, Average Price ($), Forecast, 2011-2018
Table 78: Orthobiologics, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 79: Orthobiologics, India, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 80: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018
Table 81: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 82: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 83: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Table 84: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Table 85: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011
Table 86: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018
Table 87: Bone Graft Substitutes, China, Average Price ($), Historic, 2004-2011
Table 88: Bone Graft Substitutes, China, Average Price ($), Forecast, 2011-2018
Table 89: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 90: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 91: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 92: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 93: Viscosupplementation, China, Volume (Units), Historic, 2004-2011
Table 94: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018
Table 95: Viscosupplementation, China, Average Price ($), Historic, 2004-2011
Table 96: Viscosupplementation, China, Average Price ($), Forecast, 2011-2018
Table 97: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011
Table 98: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 99: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011
Table 100: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018
Table 101: Bone Growth Stimulators, China, Average Price ($), Historic, 2004-2011
Table 102: Bone Growth Stimulators, China, Average Price ($), Forecast, 2011-2018
Table 103: Orthobiologics, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 104: Orthobiologics, China, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 105: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Table 106: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 107: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 108: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Table 109: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Table 110: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011
Table 111: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018
Table 112: Bone Graft Substitutes, South Africa, Average Price ($), Historic, 2004-2011
Table 113: Bone Graft Substitutes, South Africa, Average Price ($), Forecast, 2011-2018
Table 114: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 115: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 116: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 117: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 118: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011
Table 119: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018
Table 120: Viscosupplementation, South Africa, Average Price ($), Historic, 2004-2011
Table 121: Viscosupplementation, South Africa, Average Price ($), Forecast, 2011-2018
Table 122: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Table 123: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Table 124: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011
Table 125: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018
Table 126: Bone Growth Stimulators, South Africa, Average Price ($), Historic, 2004-2011
Table 127: Bone Growth Stimulators, South Africa, Average Price ($), Forecast, 2011-2018
Table 128: Orthobiologics, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 129: Orthobiologics, South Africa, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 130: DePuy, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 131: Genzyme Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011
Table 132: Synthes, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 133: Medtronic, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 134: Baxter International Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 135: Biomet, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 136: Orthofix International N.V., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 137: Smith & Nephew Plc, Revenue ($m), BRICS Orthobiologics Market, 2011
Table 138: Globus Medical, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 139: Wright Medical Group, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 140: Stryker Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011
Table 141: DJO Finance LLC, Revenue ($m), BRICS Orthobiologics Market, 2011
Table 142: Ferring International Center S.A., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 143: Seikagaku Corporation, Revenue ($m), BRICS Orthobiologics Market, 2011
Table 144: Anika Therapeutics, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011
Table 145: Alphatec Holdings, Inc., Revenue ($m), BRICS Orthobiologics Market, 2011

1.2 List of Figures
Figure 1: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, 2004-2018
Figure 2: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 3: Orthobiologics, BRICS, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 4: Orthobiologics, BRICS, Company share (%), 2011
Figure 5: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, 2004-2018
Figure 6: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Orthobiologics, Brazil, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Figure 9: Bone Graft Substitutes, Brazil, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Figure 10: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Historic, 2004-2011
Figure 11: Bone Graft Substitutes, Brazil, Volume (Units) by Segment, Forecast, 2011-2018
Figure 12: Bone Allografts, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 13: Bone Allografts, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 14: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 15: Viscosupplementation, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 16: Viscosupplementation, Brazil, Volume (Units), Historic, 2004-2011
Figure 17: Viscosupplementation, Brazil, Volume (Units), Forecast, 2011-2018
Figure 18: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 19: Bone Growth Stimulators, Brazil, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 20: Bone Growth Stimulators, Brazil, Volume (Units), Historic, 2004-2011
Figure 21: Bone Growth Stimulators, Brazil, Volume (Units), Forecast, 2011-2018
Figure 22: Orthobiologics, Brazil, Company Share (%), 2011
Figure 23: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, 2004-2018
Figure 24: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 25: Orthobiologics, Russian Federation, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 26: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Figure 27: Bone Graft Substitutes, Russian Federation, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Figure 28: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Historic, 2004-2011
Figure 29: Bone Graft Substitutes, Russian Federation, Volume (Units) by Segment, Forecast, 2011-2018
Figure 30: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 31: Bone Allografts, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 32: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 33: Bone Growth Stimulators, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 34: Bone Growth Stimulators, Russian Federation, Volume (Units), Historic, 2004-2011
Figure 35: Bone Growth Stimulators, Russian Federation, Volume (Units), Forecast, 2011-2018
Figure 36: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 37: Viscosupplementation, Russian Federation, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 38: Viscosupplementation, Russian Federation, Volume (Units), Historic, 2004-2011
Figure 39: Viscosupplementation, Russian Federation, Volume (Units), Forecast, 2011-2018
Figure 40: Orthobiologics, Russian Federation, Company Share (%), 2011
Figure 41: Orthobiologics, India, Overall Revenue ($m), USD Constant, 2004-2018
Figure 42: Orthobiologics, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 43: Orthobiologics, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 44: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Figure 45: Bone Graft Substitutes, India, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Figure 46: Bone Graft Substitutes, India, Volume (Units) by Segment, Historic, 2004-2011
Figure 47: Bone Graft Substitutes, India, Volume (Units) by Segment, Forecast, 2011-2018
Figure 48: Bone Allografts, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 49: Bone Allografts, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 50: Viscosupplementation, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 51: Viscosupplementation, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 52: Viscosupplementation, India, Volume (Units), Historic, 2004-2011
Figure 53: Viscosupplementation, India, Volume (Units), Forecast, 2011-2018
Figure 54: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 55: Bone Growth Stimulators, India, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 56: Bone Growth Stimulators, India, Volume (Units), Historic, 2004-2011
Figure 57: Bone Growth Stimulators, India, Volume (Units), Forecast, 2011-2018
Figure 58: Orthobiologics, India, Company Share (%), 2011
Figure 59: Orthobiologics, China, Overall Revenue ($m), USD Constant, 2004-2018
Figure 60: Orthobiologics, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 61: Orthobiologics, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 62: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Figure 63: Bone Graft Substitutes, China, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Figure 64: Bone Graft Substitutes, China, Volume (Units) by Segment, Historic, 2004-2011
Figure 65: Bone Graft Substitutes, China, Volume (Units) by Segment, Forecast, 2011-2018
Figure 66: Bone Allografts, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 67: Bone Allografts, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 68: Viscosupplementation, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 69: Viscosupplementation, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 70: Viscosupplementation, China, Volume (Units), Historic, 2004-2011
Figure 71: Viscosupplementation, China, Volume (Units), Forecast, 2011-2018
Figure 72: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 73: Bone Growth Stimulators, China, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 74: Bone Growth Stimulators, China, Volume (Units), Historic, 2004-2011
Figure 75: Bone Growth Stimulators, China, Volume (Units), Forecast, 2011-2018
Figure 76: Orthobiologics, China, Company Share (%), 2011
Figure 77: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018
Figure 78: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 79: Orthobiologics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 80: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Historic, 2004-2011
Figure 81: Bone Graft Substitutes, South Africa, Revenue ($m) by Segment, USD Constant, Forecast, 2011-2018
Figure 82: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Historic, 2004-2011
Figure 83: Bone Graft Substitutes, South Africa, Volume (Units) by Segment, Forecast, 2011-2018
Figure 84: Bone Allografts, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 85: Bone Allografts, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 86: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 87: Viscosupplementation, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 88: Viscosupplementation, South Africa, Volume (Units), Historic, 2004-2011
Figure 89: Viscosupplementation, South Africa, Volume (Units), Forecast, 2011-2018
Figure 90: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Historic, 2004-2011
Figure 91: Bone Growth Stimulators, South Africa, Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 92: Bone Growth Stimulators, South Africa, Volume (Units), Historic, 2004-2011
Figure 93: Bone Growth Stimulators, South Africa, Volume (Units), Forecast, 2011-2018
Figure 94: Orthobiologics, South Africa, Company Share (%), 2011
Figure 95: DePuy, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 96: Genzyme Corporation, Company Share (%), BRICS Orthobiologics Market, 2011
Figure 97: Synthes, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 98: Medtronic, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 99: Baxter International Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 100: Biomet, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 101: Orthofix International N.V., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 102: Smith & Nephew Plc, Company Share (%), BRICS Orthobiologics Market, 2011
Figure 103: Wright Medical Group, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 104: Stryker Corporation, Company Share (%), BRICS Orthobiologics Market, 2011
Figure 105: DJO Finance LLC, Company Share (%), BRICS Orthobiologics Market, 2011
Figure 106: Ferring International Center S.A., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 107: Anika Therapeutics, Inc., Company Share (%), BRICS Orthobiologics Market, 2011
Figure 108: Alphatec Holdings, Inc., Company Share (%), BRICS Orthobiologics Market, 2011

- DePuy, Inc.
- Genzyme Corporation
- Synthes, Inc.
- Medtronic, Inc.
- Baxter International Inc.
- Biomet, Inc.
- Orthofix International N.V.
- Smith & Nephew Plc
- Globus Medical, Inc.
- Wright Medical Group, Inc.
- Stryker Corporation
- DJO Finance LLC
- Ferring International C

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos